PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()

The potential of PACE4 as a pharmacological target in prostate cancer has been demonstrated as this proprotein convertase is strongly overexpressed in human prostate cancer tissues and its inhibition, using molecular or pharmacological approaches, results in reduced cell proliferation and tumor prog...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neoplasia
Asıl Yazarlar: Couture, Frédéric, Levesque, Christine, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, D’Anjou, François, Day, Robert, Guérin, Brigitte
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235008/
https://ncbi.nlm.nih.gov/pubmed/25220591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller